START
Return
Access
EMCDDA update on the implications of COVID-19 for people who use drugs (PWUD) and drug service providers
EMCDDA. European Monitoring Centre for Drugs and Drug Addiction
The purpose of this briefing is to highlight emerging risks linked to the COVID-19 pandemic for people who use drugs and those providing services for them from a European perspective, and where necessary to encourage planning, review and adaption of frontline and specialist drug interventions.
The European Commission is preparing a third phase of this programme, therefore COPOLAD will be back at the beginning of 2021.